Sotera Health (SHC) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Sotera Health · Health Care · ref. ETF XLV · 50 calls · price $19.48
What the company does: Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
📈 Sotera Health (SHC) stock price
$19.48+20.2% over range
Aug 28, 25low $13.13 · high $19.57Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 5 analysts
📊 JPI status : Sotera Health has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 SHC price target & analyst consensus — price $19.48
The price target · all analysts combined (5 targets)
Highest target · 2 firms of 5$25+28.3%
Median target · of 5 targets$22+12.9%
Lowest target · 1 firm of 5$18-7.6%
Current price$19.48
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
480%
$20 ↔ $25
Below
120%
$18
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Citigroup — 64% of its targets hit on this sector (125 calls tested). It aims for $25 (+28 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).
The 2 reliable analysts
$22.50+16 %
The 3 other firms
$22+13 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $22.50 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 SHC price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on SHC most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in SHC? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Sotera Health? The JPI assistant answers using our backtest data.
📈 Sotera Health fundamentals: valuation, margins & growth › open the full page
P/E 34.2Net margin 13.4 %Revenue growth +9.2 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -23 %
2023
Rev +5%
2024
Rev +5%Profit −14%
2025
Rev +6%Profit +76%
🔎 Detailed analyses
✅ Historical analyst reliability on SHC
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Jefferies ↗ | 50% | -6.6% | 2 |
| Goldman Sachs ↗ | 33% | -3.7% | 3 |
| RBC Capital ↗ | 30% | +3.9% | 10 |
| Barclays ↗ | 29% | -12.9% | 17 |
| Citigroup ↗ | 0% | -5.1% | 2 |
| Credit Suisse | 0% | -16.1% | 2 |
| Wolfe Research ↗ | 0% | -17.7% | 2 |
| Keybanc ↗ | 0% | -23.6% | 5 |
| JP Morgan ↗ | 0% | -110.4% | 2 |
📊 What $1,000 invested in Sotera Health would be worth › open the full page
In short — $1,000 invested in Sotera Health 10 years ago would be worth $707 today, i.e. -6%/yr on average. Best year: 2023 (+102%), worst: 2022 (-65%). Price performance, excluding dividends.
If I'd invested $1,000 in Sotera Health
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,302 | +30% |
| 3 years ago | $2,131 | +113% |
| 5 years ago | $647 | -35% |
Return by year (Sotera Health)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +0% | $1,003 (+0%) |
| 2025 | +30% | $1,302 (+30%) |
| 2024 | -19% | $1,053 (+5%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Sotera Health
Loading news…
📋 All analyst calls on SHC
Filtered on — · ✕ show all
▲ Buy · 🎯$25
Price at call : $18.97 — upside +32%
Today : $19.48 — upside +28%
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Overweight · 🎯$22
Price at call : $18.97 — upside +16%
Today : $19.48 — upside +13%
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Piper Sandler ↗
Aug 7, 26
▲ Overweight · 🎯$25
Price at call : $18.97 — upside +32%
Today : $19.48 — upside +28%
🎯 on SHC : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
■ Neutral neutral · not a buy · 🎯$18
Price at call : $18.97 — gap to target -5%
Today : $19.48 — gap to target -8%
🎯 on SHC : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Overweight · 🎯$19
Price at call : $17.1 — upside +11%
Today : $19.48 — upside -2%
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
Goldman Sachs ↗
Jun 5, 26
▲ Buy · 🎯$20
Price at call : $15.62 — upside +28%
Today : $19.48 — upside +3%
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
Piper Sandler ↗
May 6, 26
▲ Overweight · 🎯$22
Price at call : $15.67 — upside +40%
Today : $19.48 — upside +13%
🎯 on SHC : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Overweight · 🎯$18
Price at call : $16.03 — upside +12%
Today : $19.48 — upside -8%
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
See the other 42 calls, newest to oldest
▲ Buy · 🎯$23
Price at call : $16.16 — upside +42%
Today : $19.48 — upside +18%
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
Piper Sandler ↗
Jan 9, 26
▲ Overweight · 🎯$24
Price at call : $19.2 — upside +25%
Today : $19.48 — upside +23%
🎯 on SHC : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
William Blair ↗
Dec 18, 25
▲ Outperform
🎯 on SHC : no call matured yet · 📊 on Health : 50% · +37.8% (20 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
BMO Capital ↗
Nov 13, 25
▲ Outperform · 🎯$19
Price at call : $16.01 — upside +19%
Today : $19.48 — upside -2%
🎯 on SHC : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
■ Neutral neutral · not a buy · 🎯$16
Price at call : $16.01 — gap to target -0%
Today : $19.48 — gap to target -18%
🎯 on SHC : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
▲ Overweight · 🎯$20
Price at call : $16.01 — upside +25%
Today : $19.48 — upside +3%
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Piper Sandler ↗
Nov 5, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.01 — gap to target +6%
Today : $19.48 — gap to target -13%
🎯 on SHC : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
▲ Overweight · 🎯$19
Price at call : $15.88 — upside +20%
Today : $19.48 — upside -2%
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
▲ Overweight · 🎯$13
Price at call : $11.14 — upside +17%
Today : $19.48 — upside -33%
Expected +17% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+53.5%
stock +54% · XLV +16%
matured Jun 24, 26
Goldman Sachs ↗
May 5, 25
▲ Buy · 🎯$17
Price at call : $12.92 — upside +32%
Today : $19.48 — upside -13%
Expected +32% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 57.9% · +13.8% (107 calls)
+18.6%
stock +19% · XLV +5%
matured May 5, 26
Piper Sandler ↗
Apr 23, 25
■ Neutral neutral · not a buy · 🎯$13
Price at call : $11.3 — gap to target +15%
Today : $19.48 — gap to target -33%
🎯 on SHC : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Apr 23, 26
matures : Apr 23, 26
▲ Overweight · 🎯$12
Price at call : $10.51 — upside +14%
Today : $19.48 — upside -38%
Expected +14% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+49.4%
stock +49% · XLV +8%
matured Apr 10, 26
▲ Overweight · 🎯$16
Price at call : $11.68 — upside +37%
Today : $19.48 — upside -18%
Expected +37% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+36.2%
stock +36% · XLV +6%
matured Feb 28, 26
▲ Overweight · 🎯$17
Price at call : $13.5 — upside +26%
Today : $19.48 — upside -13%
Expected +26% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+29.3%
stock +29% · XLV +9%
matured Feb 18, 26
RBC Capital ↗
Nov 21, 24
▲ Outperform · 🎯$17
Price at call : $12.82 — upside +33%
Today : $19.48 — upside -13%
Expected +33% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+30.9%
stock +31% · XLV +8%
matured Nov 21, 25
▲ Buy · 🎯$20
Price at call : $15.83 — upside +26%
Today : $19.48 — upside +3%
Expected +26% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56% · +15.7% (125 calls)
-0.9%
stock -1% · XLV -2%
matured Nov 6, 25
▲ Overweight · 🎯$17
Price at call : $14.39 — upside +18%
Today : $19.48 — upside -13%
Expected +18% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-22.0%
stock -22% · XLV -12%
matured Aug 6, 25
RBC Capital ↗
Aug 6, 24
▲ Outperform · 🎯$17
Price at call : $14.7 — upside +16%
Today : $19.48 — upside -13%
Expected +16% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-24.8%
stock -25% · XLV -12%
matured Aug 6, 25
Piper Sandler ↗
May 21, 24
■ Neutral neutral · not a buy · 🎯$13
Price at call : $10.89 — gap to target +19%
Today : $19.48 — gap to target -33%
🎯 on SHC : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : May 21, 25
matures : May 21, 25
▲ Overweight · 🎯$14
Price at call : $11.42 — upside +23%
Today : $19.48 — upside -28%
Expected +23% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-8.0%
stock -8% · XLV -3%
matured Apr 10, 25
▲ Buy · 🎯$16
Price at call : $11.4 — upside +40%
Today : $19.48 — upside -18%
Expected +40% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 56% · +15.7% (125 calls)
-9.3%
stock -9% · XLV -5%
matured Apr 3, 25
▲ Buy · 🎯$15.5
Price at call : $11.75 — upside +32%
Today : $19.48 — upside -20%
Expected +32% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 49.1% · +10.3% (112 calls)
+1.5%
stock +2% · XLV +0%
matured Mar 25, 25
RBC Capital ↗
Mar 11, 24
▲ Outperform · 🎯$20
Price at call : $13.77 — upside +45%
Today : $19.48 — upside +3%
Expected +45% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-18.1%
stock -18% · XLV -2%
matured Mar 11, 25
RBC Capital ↗
Mar 4, 24
▲ Outperform · 🎯$20
Price at call : $14 — upside +43%
Today : $19.48 — upside +3%
Expected +43% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-15.6%
stock -16% · XLV +3%
matured Mar 4, 25
▲ Overweight · 🎯$19
Price at call : $15.01 — upside +27%
Today : $19.48 — upside -2%
Expected +27% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-16.9%
stock -17% · XLV +3%
matured Feb 27, 25
■ Sector Weight neutral · not a buy
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Feb 5, 25
matures : Feb 5, 25
▲ Overweight · 🎯$17
Price at call : $14.98 — upside +13%
Today : $19.48 — upside -13%
Expected +13% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-6.9%
stock -7% · XLV +6%
matured Jan 24, 25
RBC Capital ↗
Nov 2, 23
▲ Outperform · 🎯$20
Price at call : $13.21 — upside +51%
Today : $19.48 — upside +3%
Expected +51% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+19.6%
stock +20% · XLV +15%
matured Nov 1, 24
▲ Overweight · 🎯$15
Price at call : $13.21 — upside +14%
Today : $19.48 — upside -23%
Expected +14% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+19.6%
stock +20% · XLV +15%
matured Nov 1, 24
RBC Capital ↗
Aug 4, 23
▲ Outperform · 🎯$22
Price at call : $16.89 — upside +30%
Today : $19.48 — upside +13%
Expected +30% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-15.8%
stock -16% · XLV +10%
matured Aug 3, 24
▲ Overweight · 🎯$23
Price at call : $17.8 — upside +29%
Today : $19.48 — upside +18%
Expected +29% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
-20.1%
stock -20% · XLV +11%
matured Aug 3, 24
▲ Overweight · 🎯$24
Price at call : $18.42 — upside +30%
Today : $19.48 — upside +23%
Expected +30% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
-35.2%
stock -35% · XLV +12%
matured Jun 25, 24
■ Sector Weight neutral · not a buy
🎯 on SHC : 0% (2 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Jun 21, 24
matures : Jun 21, 24
RBC Capital ↗
May 4, 23
▲ Outperform · 🎯$18
Price at call : $15.02 — upside +20%
Today : $19.48 — upside -8%
Expected +20% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-24.8%
stock -25% · XLV +6%
matured May 3, 24
▲ Overweight · 🎯$20
Price at call : $15.05 — upside +33%
Today : $19.48 — upside +3%
Expected +33% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-26.8%
stock -27% · XLV +6%
matured May 3, 24
▲ Overweight · 🎯$21
Price at call : $17.1 — upside +23%
Today : $19.48 — upside +8%
Expected +23% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-32.5%
stock -33% · XLV +10%
matured Apr 3, 24
RBC Capital ↗
Mar 1, 23
▲ Outperform · 🎯$19
Price at call : $17.08 — upside +11%
Today : $19.48 — upside -2%
Expected +11% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 25% (8 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-12.1%
stock -12% · XLV +14%
matured Feb 29, 24
■ Neutral neutral · not a buy · 🎯$18
Price at call : $17.3 — gap to target +4%
Today : $19.48 — gap to target -8%
🎯 on SHC : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jan 23, 24
matures : Jan 23, 24
▲ Overweight · 🎯$22
Price at call : $17.64 — upside +25%
Today : $19.48 — upside +13%
Expected +25% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 38% (13 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-13.5%
stock -13% · XLV +4%
matured Jan 11, 24
Wolfe Research ↗
Jan 11, 23
▲ Outperform · 🎯$25
Price at call : $17.64 — upside +42%
Today : $19.48 — upside +28%
Expected +42% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on SHC : 0% (1 call matured) · 📊 on Health : 46.2% · +2.9% (13 calls)
-13.5%
stock -13% · XLV +4%
matured Jan 11, 24
Goldman Sachs ↗
Nov 23, 22
■ Neutral neutral · not a buy · 🎯$8
Price at call : $8.15 — gap to target -2%
Today : $19.48 — gap to target -59%
🎯 on SHC : 100% (1 call matured) · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Nov 23, 23
matures : Nov 23, 23
Frequently asked questions
Should I buy Sotera Health stock?
This isn't buy advice. For Sotera Health, the analyst consensus is "Buy", with an average price target of $22.00 (+13% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on Sotera Health). We show the numbers — you decide.
Is it too late to buy Sotera Health? How high can it go?
The most bullish analyst target on Sotera Health is $25.00 (+28% above today's price); the average is $22.00. That's the upside they see. Check how reliable those analysts have actually been on Sotera Health on our site before trusting it.
Is Sotera Health still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on Sotera Health, the best hitting 50% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Sotera Health? The case for and against
The arguments for and against, one by one, from the numbers: why invest in SHC (and why hesitate).
What has Sotera Health's past performance been?
Historical returns and a "how much if I had invested" calculator: SHC performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX